Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years

BACKGROUND: Bisphosphonate (BP) therapy has been associated with atypical femur fracture (AFF). However, the threshold of treatment duration leading to increased AFF risk is unclear. In a retrospective cohort of older women initiating BP, we compared the AFF risk associated with treatment for at lea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Musculoskelet Disord
Main Authors: Lo, Joan C., Neugebauer, Romain S., Ettinger, Bruce, Chandra, Malini, Hui, Rita L., Ott, Susan M., Grimsrud, Christopher D., Izano, Monika A.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7713036/
https://ncbi.nlm.nih.gov/pubmed/33272248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-020-03672-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados